Transmural remission characterized by high biologic concentrations demonstrates better prognosis in Crohn's disease.

Kento TakenakaAmi KawamotoYoshio KitazumeToshimitsu FujiiYumi UdagawaHiromichi ShimizuShuji HibiyaMasakazu NagahoriKazuo OhtsukaMamoru WatanabeRyuichi Okamoto

Published in: Journal of Crohn's & colitis (2022)

Transmural remission was the best predictor for prognosis in CD patients who received maintenance biologic therapy. High drug concentration levels were associated with transmural remission confirmed via MRE.

Keyphrases

disease activity
rheumatoid arthritis
ulcerative colitis
systemic lupus erythematosus
emergency department
mesenchymal stem cells
smoking cessation